| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2024-09-11 20:34:17 UTC |
|---|
| Updated at | 2024-09-11 20:34:17 UTC |
|---|
| NP-MRD ID | NP0339230 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Heptanoylcarnitine |
|---|
| Description | Heptanoylcarnitine is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Heptanoylcarnitine was first documented in 2020 (PMID: 32101032). Based on a literature review a small amount of articles have been published on Heptanoylcarnitine (PMID: 39182606) (PMID: 38438006) (PMID: 36510714). |
|---|
| Structure | CCCCCCC(=O)OC(CC([O-])=O)C[N+](C)(C)C InChI=1/C14H27NO4/c1-5-6-7-8-9-14(18)19-12(10-13(16)17)11-15(2,3)4/h12H,5-11H2,1-4H3 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C14H27NO4 |
|---|
| Average Mass | 273.3730 Da |
|---|
| Monoisotopic Mass | 273.19401 Da |
|---|
| IUPAC Name | 3-(heptanoyloxy)-4-(trimethylazaniumyl)butanoate |
|---|
| Traditional Name | O-heptanoylcarnitine |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCCCCCC(=O)OC(CC([O-])=O)C[N+](C)(C)C |
|---|
| InChI Identifier | InChI=1/C14H27NO4/c1-5-6-7-8-9-14(18)19-12(10-13(16)17)11-15(2,3)4/h12H,5-11H2,1-4H3 |
|---|
| InChI Key | VDPCTFWULDLKHT-UHFFFAOYNA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| Not Available | | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Classification | Not classified |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| External Links |
|---|
| HMDB ID | Not Available |
|---|
| DrugBank ID | Not Available |
|---|
| Phenol Explorer Compound ID | Not Available |
|---|
| FoodDB ID | Not Available |
|---|
| KNApSAcK ID | Not Available |
|---|
| Chemspider ID | Not Available |
|---|
| KEGG Compound ID | Not Available |
|---|
| BioCyc ID | Not Available |
|---|
| BiGG ID | Not Available |
|---|
| Wikipedia Link | Not Available |
|---|
| METLIN ID | Not Available |
|---|
| PubChem Compound | Not Available |
|---|
| PDB ID | Not Available |
|---|
| ChEBI ID | 74303 |
|---|
| Good Scents ID | Not Available |
|---|
| References |
|---|
| General References | - Sobhi HF, Mercer KE, Lan RS, Yeruva L, Ten Have GAM, Deutz NEP, Piccolo BD, Debedat J, Pack LM, Adams SH: Novel odd-chain cyclopropane fatty acids: detection in a mammalian lipidome and uptake by hepatosplanchnic tissues. J Lipid Res. 2024 Aug 27;65(10):100632. doi: 10.1016/j.jlr.2024.100632. [PubMed:39182606 ]
- Hu T, Zhang W, Han F, Zhao R, Liu H, An Z: Machine learning reveals serum myristic acid, palmitic acid and heptanoylcarnitine as biomarkers of coronary artery disease risk in patients with type 2 diabetes mellitus. Clin Chim Acta. 2024 Mar 15;556:117852. doi: 10.1016/j.cca.2024.117852. Epub 2024 Mar 2. [PubMed:38438006 ]
- Liu XD, Meng XJ, Zhang XM, Li J, Pan XF: [A non-targeted metabolomics study on serum of occupational people exposed with nanometer titanium dioxide particles (TiO(2)-NPs)]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2022 Nov 20;40(11):813-820. doi: 10.3760/cma.j.cn121094-20210318-00158. [PubMed:36510714 ]
- Sobhi HF, Zhao X, Plomgaard P, Hoene M, Hansen JS, Karus B, Niess AM, Haring HU, Lehmann R, Adams SH, Xu G, Weigert C: Identification and regulation of the xenometabolite derivatives cis- and trans-3,4-methylene-heptanoylcarnitine in plasma and skeletal muscle of exercising humans. Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E701-E709. doi: 10.1152/ajpendo.00510.2019. Epub 2020 Feb 26. [PubMed:32101032 ]
|
|---|